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Enzymatic Breakdown of Type II Collagen in the
Human Vitreous
Marie¨lle van Deemter,1 Hendri H. Pas,2 Roel Kuijer,3 Roelofje J. van der Worp,1,3
Johanna M. M. Hooymans,1 and Leonoor I. Los1
PURPOSE. To investigate whether enzymatic collagen break-
down is an active process in the human vitreous.
METHODS. Human donor eyes were used for immunohisto-
chemistry to detect the possible presence of the matrix met-
alloproteinase (MMP)-induced type II collagen breakdown
product col2-3/4C-short in the vitreous. Western blot and slot
blot analyses were used to further identify vitreal type II col-
lagen breakdown products in three age groups with average
ages of 25, 45, and 65 years. Purified type II collagen was
cleaved by MMPs that are known to occur naturally in the
vitreous to elucidate what possible type II collagen breakdown
products could thus be formed in the human vitreous.
RESULTS. By means of both immunohistochemistry and slot blot
analysis, col2-3/4C-short was detected in the vitreous. Using
Western blot analysis, a range of type II collagen breakdown
products was found, mostly in younger eyes, but none of these
products contained the neoepitope that characterizes the col2-
3/4C-short molecule. Digestion of purified type II collagen by
MMPs did not give the same breakdown products as found in
the vitreous.
CONCLUSIONS. The presence of collagen degradation products in
the human vitreous supports the hypothesis that enzymatic
breakdown is most likely an active process in this extracellular
matrix. Based on the size of the degradation products found by
Western blot analysis, it is likely that in addition to MMPs, other
proteolytic enzymes able to digest type II collagen are also
active. (Invest Ophthalmol Vis Sci. 2009;50:4552–4560) DOI:
10.1167/iovs.08-3125
The vitreous body is the gel-like extracellular matrix in theeye that fills the space between the lens and the retina. It
has functions in eye growth, in applying turgescent pressure,
and in maintaining the eye’s optical transparency by prevent-
ing cells from entering the vitreous cavity. With a water con-
tent of 98% to 99%, it is highly hydrated. Furthermore, the low
protein concentration minimizes light scattering, thus contrib-
uting to optimized vision.1,2 With aging, the vitreous body
undergoes structural changes, resulting in the formation of
liquid-filled spaces (synchysis) and optically dense condensa-
tions within the matrix (syneresis).3,4 Liquefaction and col-
lapse of the matrix can be followed by posterior vitreous
detachment5–8 that can induce pathologic conditions such as
retinal tears, retinal detachment, and intravitreal hemorrhage.9
The most important structural components of the vitreous
body are collagens. These are assembled as fibrils, consisting of
a type V/XI collagen core surrounded by type II collagen and a
coating of type IX collagen.10,11 Type II collagen is predomi-
nant and consists of approximately 80% of total vitreous colla-
gen. In vitro studies in ox vitreous12 and in vivo studies in
chick vitreous13 have shown that when vitreous collagen is
broken down enzymatically the gel structure disappears. Hy-
dration of the gel is maintained primarily by the presence of
hyaluronan, a high molecular weight glycosaminoglycan capa-
ble of binding large quantities of water.14 Proteoglycans, of
which type IX collagen is one, apparently maintain the spacing
between collagen fibrils.3
Previous studies speculated that the mechanisms underly-
ing synchisis and syneresis were interrelated. Initially it was
speculated that morphologic changes of the vitreous are
caused by the mechanical unmixing of the collagenous and
non-collagenous components.1 Later, Bishop3,10 hypothesized
that synchisis and syneresis may be caused by the gradual loss
of proteoglycan coating from collagen fibrils that is seen with
aging. Sticky collagen fibrils would then be able to contact
each other and aggregate; simultaneously, the areas that con-
sequently lacked the presence of collagen fibrils would be
converted from a gel to a liquid phase. However, in a light and
electron microscopic study by Los et al.4 on structural changes
in the vitreous, no prominent aggregation of intact collagen
fibrils was observed in the vicinity of the liquefied spaces.
Instead, fragmentation of the collagen fibrils was detected.
Bishop3 hypothesized that enzymes were likely to be involved
in the loss of proteoglycans from the collagen fibrils. In line
with this, we propose that enzymatic degradation may also be
involved in the fragmentation of type II collagen in the vitre-
ous.
Given that the vitreous is an extracellular matrix (ECM), it
seems plausible that the fragmentation of the collagen fibrils is
caused by endogenous breakdown induced by matrix-related
proteolytic enzymes. Important enzymes involved in the re-
modeling and breakdown of ECMs are the matrix metallopro-
teinases (MMPs), which together can break down all ECM
components. In cartilage, MMP-13 is the most likely enzyme to
degrade type II collagen because it is produced by chondro-
cytes and cleaves type II collagen far more efficiently than the
other collagenases.15,16 The first cleavage occurs at gly775-leu/
ile776, thereby generating the characteristic 3/4 N-terminal and
1/4 C-terminal fragments.17 MMP-1 and MMP-8 are also capable
of cleaving intact type II collagen at the same site. After this
initial cleavage, the triple helical structure is lost, and the
collagen becomes susceptible to further enzymatic breakdown
by other enzymes. Several MMPs have been discovered in the
vitreous, among them the collagenases MMP-1 and MMP-8 and
the gelatinases MMP-2 and MMP-9.18,19
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Our study focuses on whether enzymatic collagen break-
down is an active process in the human vitreous. Therefore, in
several age groups we analyzed whether, in addition to intact
collagen triple helices, collagen breakdown products also oc-
cur naturally in the vitreous body. We demonstrate that frag-
ments of collagen are indeed present. In addition we analyzed
the possible involvement of MMPs in vitreous collagen frag-
mentation.
MATERIALS AND METHODS
Human eyes with no known ophthalmic disorders were obtained from
the Cornea Bank (Amsterdam, The Netherlands) after removal of the
corneas for transplantation (n  39; age range, 15–74 years). Informa-
tion on refractive errors of the eyes or their axial lengths before
removal of the corneas was not available. However, eyes that seemed
to be exceptionally large or small were not included in this study.
Three specimens were used for histology (ages 55, 69, and 74 years)
and thus were embedded in paraffin within 48 hours of death; all
others were used for analysis of type II collagen breakdown products.
Isolation of the vitreous bodies was performed by first cleaving the
sclera. Then the choroid, lens, and retina were removed. Finally, the
pars plana remnants of the ciliary body were carefully cleaved. The
isolated vitreous bodies were washed and frozen at 80°C, within 48
hours of death. Before analysis, pools were formed of four vitreous
bodies each, arranged according to age group. Three age groups were
formed: P25, average age 25 years; P45, average age 45 years; and P65,
average age 65 years.
Porcine eyes (n  6), obtained from a local abattoir, were used for
analysis of the effect of postmortem time on type II collagen and its
breakdown products. Vitreous bodies were isolated within 2 hours of
death or after 24 hours or 1 week of storage at 4°C (n 2 of each time
point). Isolation and analysis of type II collagen breakdown products
was then performed.
Human cartilage obtained from the knees of two patients with
osteoarthritis was used for the preparation of positive and negative
controls for immunohistochemistry and Western blot analysis. Areas of
healthy and degenerated cartilage in one sample were identified by
macroscopic examination; regions or cartilage that looked macroscop-
ically normal were defined as healthy cartilage, whereas soft, dull
cartilage with lacerations was classified as osteoarthritic. Pieces of both
were embedded in paraffin and used for immunohistochemical analy-
sis. Nonclassified pieces of cartilage from the second sample were
frozen and pulverized and used for collagen isolation. Unless otherwise
mentioned, all reagents used were of analytical grade.
Paraffin Embedding and Immunohistochemistry
Human eyes and pieces of healthy knee cartilage and osteoarthritic,
degenerated knee cartilage were embedded in paraffin. The samples
were fixed overnight in 2% paraformaldehyde in phosphate-buffered
saline (PBS) and then washed. This was followed by four 45-minute
dehydration steps in 50% ethanol that were gradually increased to
100% ethanol and then by two additional 45-minute incubations in
100% ethanol. Next, the samples were incubated for 3 45 minutes in
xylol, followed by a 1-hour incubation in paraffin at 60°C. Then the
samples were incubated overnight in fresh paraffin at 60°C followed by
embedding at room temperature.
Sagittal sections 5-m thick were mounted on slides, dried over-
night at 37°C, and underwent the following procedures. First, the
sections were deparaffinized by incubation in xylol, 100% ethanol, 96%
ethanol, and 70% ethanol and were washed in distilled water. Then the
sections were treated for 30 minutes at room temperature with 0.01%
type XXIV protease (Sigma-Aldrich, St. Louis, MO) and were washed in
PBS. Sections were blocked by means of 30-minute incubation in PBS,
2% bovine serum albumin (BSA), and 5% serum (host of the secondary
antibody) and were washed in PBS. The primary antibody was either
mouse-anti–type II collagen Ab-3, which binds on the N-terminal 3/4
part of type II collagen (Lab Vision, Fremont, CA), or rabbit-anti–col2-
3/4C-short (C12C Ab 2699; IBEX Diagnostics, Montreal, Canada),
which specifically binds the neoepitope on the 3/4-end of the type II
collagen fragment formed on cleavage with MMP-1, MMP-8, or MMP-
13.17 Sections were incubated with antibodies diluted 1:50 in PBS, 1%
BSA, for 1 hour at 37°C, followed by 3  5-minute washes in PBS.
Negative control sections were incubated in PBS and 1% BSA without
the primary antibody. Then the sections were incubated in PBS and
0.1% H2O2 for 15 minutes, followed by washing in PBS. The secondary
antibody was either horseradish peroxidase-conjugated rabbit-anti–
mouse or horseradish peroxidase-conjugated swine-anti–rabbit (Dako,
Carpinteria, CA), depending on the first antibody. Sections were incu-
bated with antibodies diluted 1:100 in PBS, 1% BSA, 2% serum for 45
minutes at room temperature, and 3  5-minute washes in PBS.
Staining was then performed by incubating in 3-amino-9-ethylcarbazole
(Sigma-Aldrich). The sections were briefly rinsed with distilled water,
followed by staining with hematoxylin. After thorough rinsing with
running tap water, Kaiser glycerol gelatin (Merck, Darmstadt, Ger-
many) was added, and the sections were covered with a coverslip.
Isolation of Collagen and Collagen Fragments
from Vitreous
Collagen was isolated according to a method adapted from Brown et
al.20 Pools consisting of four vitreous bodies each and subdivided into
three different age groups were homogenized with a homogenizer
(DIAX 600; Heidolph, Kelheim, Germany). This was followed by
2-hour centrifugation at 30,000g. The supernatants were stored at
80°C to determine the presence of type II collagen fragments, as
described. The pellets were resuspended in 2 mL of 0.5 M acetic acid
(HAc) containing 0.1% pepsin (Sigma-Aldrich) and incubated for 24
hours at 4°C while gently rotating. Insoluble proteins were removed
from the solution by centrifuging for 30 minutes at 16,000g. Soluble
proteins were obtained by adding crystalline NaCl in a final concen-
tration of 3 M to the solution. After overnight incubation at 4°C under
gentle rotation, the precipitates were centrifuged for 30 minutes at
16,000g and were dissolved in 0.5 M HAc. This was dialyzed against 0.1
M HAc, after which the protein concentration was determined by
measuring the absorption at 280 nm (A280) using a spectrophotometer
(Nanodrop; Isogen, Maarssen, The Netherlands). The samples were
lyophilized and stored at 80°C until further use. For all experiments
the lyophilized samples were redissolved in 0.5 M HAc at a concentra-
tion of 1 mg/mL. These pepsin extracts of the different age groups
were labeled P25-P, P45-P, and P65-P.
Supernatants obtained at the first centrifugation step were used
without further treatment (labeled P25-S, P45-S, and P65-S) or, depending
on the experiment, were concentrated by ultrafiltration (labeled P25-SC,
P45-SC, and P65-SC). Before concentrating, the supernatant was first
filtered through a 50-kDa filter (Amicon Ultra; Millipore, Billerica, MA)
so that larger proteins that could clot the 10-kDa filter (Amicon Ultra;
Millipore) in the next step could be removed. The flow through of the
50-kDa filter was then concentrated 100 times with the 10-kDa filter.
Isolation of type II collagen and type II collagen breakdown prod-
ucts from the separate porcine vitreous bodies was performed in a way
similar to the method described, except that the pellets were resus-
pended in 0.5 mL 0.1% pepsin in 0.5 M HAc. Porcine supernatants
were not analyzed.
Isolation of Collagen from
Osteoarthritic Cartilage
Type II collagen was isolated from osteoarthritic cartilage according to
a method of Kuijer et al.21 Cartilage powder was extracted in 50 mM
Tris-HCl, pH 7.4, containing 4 M guanidinium-HCl for 2  24 hours,
followed by 30 minutes centrifugation at 60,000g. The pellet was
washed three times in ice-cold distilled water and suspended in 0.5 M
HAc containing 1 g pepsin per 20 g wet-weight cartilage (final pepsin
concentration, 1 mg/mL). This was incubated for 24 hours at 4°C,
followed by 30-minute centrifugation at 60,000g. The supernatant was
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collected, and type II collagen was precipitated by dialyzing against 0.5
M HAc  0.9 M NaCl for 24 hours at 4°C, followed by 30-minute
centrifugation at 60,000g. The precipitate was dissolved in 0.5 M HAc,
dialyzed against 0.1 M HAc, and lyophilized. The dried collagen was
stored at 80°C until further use.
Western Blot Analysis
Analysis of collagen and the collagen fragments was performed by
means of SDS-PAGE with the use of 10% and 20% polyacrylamide slab
gels, followed by Western blot analysis. As a control, the pepsin
solution used for the extraction of type II collagen was also analyzed by
means of Western blot analysis. Unless otherwise mentioned, the
protein concentration used was always 1 mg/mL. A blocking step was
performed by incubation of the blotting membranes for 1 hour at room
temperature in Tris-buffered saline (TBS; 20 mM Tris, 0.5 M NaCl, pH
7.5) containing 2% skimmed milk powder. This was followed by
overnight incubation at room temperature in TBS  0.05% Tween-20
(TBST), containing mouse-anti–type II collagen Ab-3, mouse-anti–type
II collagen Ab-2, which binds on the C-terminal 1/4 part of type II
collagen (Lab Vision), or rabbit-anti–col2-3/4C-short. Negative controls
were incubated overnight at room temperature in TBST without the
primary antibody. Secondary antibodies were goat-anti–mouse and
mouse-anti–rabbit (Jackson ImmunoResearch Laboratories, Inc.,
Carpinteria, CA), and tertiary antibodies were alkaline phosphatase
(AP) conjugated rabbit-anti–goat (Jackson ImmunoResearch Laborato-
ries, Inc.) and AP conjugated goat-anti–mouse (Bio-Rad, Hercules, CA).
Secondary and tertiary antibodies were diluted 1:1000 in TBST, and the
incubation time was 1 hour for each. Between the different antibody
incubations, the membranes were washed 3  5 minutes in TBST.
After the third antibody incubation step, the membranes were washed
2  5 minutes in TBST and 2  5 minutes in AP-buffer (20 mM Tris, 20
mM NaCl, 1 mM MgCl2, pH 9.5). Protein bands were visualized by
incubation in nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phos-
phate solution (Bio-Rad).
Slot Blot Analysis
Slot blot analysis was performed by applying 20 L of either pepsin-
extracted vitreous collagen or unconcentrated vitreous supernatant
into the slots of the slot-blot apparatus (Bio-Rad). As a positive control
for the presence of col2-3/4C-short, cartilage type II collagen was
cleaved with MMP-8, and 20 L was then applied. The membrane was
blocked by incubation for 1 hour in 5% skimmed milk and then was
stained with the same antibodies and protocol used for Western blot
staining.
Densitometry of Collagen Bands
Relative amounts of collagen in the pepsin extracts from the vitreous
of the different age groups were determined by means of densitometry
performed with a computer program (Quantiscan; Biosoft, Cambridge,
UK) according to the manufacturer’s instructions. A dilution series was
made of P25-P, of which the concentration of 1 mg/mL was arbitrarily
set to 100%, and these were electrophoresed next to the samples. The
final immunoblot was scanned, and the relative protein concentrations
in P45-P and P65-P were calculated (Quantiscan; Biosoft).
Collagenase Treatment
To confirm the collagen nature of the isolated fragments, the samples
were treated with collagenase type VII from Clostridium histolyticum
(Sigma-Aldrich). Two 20-L aliquots of protein sample from P25-P were
applied onto separate 10-kDa molecular weight cutoff filtration col-
umns (Amicon Ultra; Millipore), and 500 L TESCA buffer (50 mM TES
[Sigma-Aldrich], 0.36 mM CaCl, pH 7.5) was added to each. This was
filtrated by centrifugation at 4000g until a volume of approximately
100 L was left on the filter, after which these washing steps were
repeated. The pH was checked for neutrality by pH indicator paper.
Ten units of collagenase in TESCA buffer were added to one sample,
and the same volume of TESCA buffer without the enzyme was added
to the control sample, and both were incubated at 37°C for 5 hours.
TESCA buffer was then replaced by 0.5 M HAc according to the same
washing procedure used on the 10-kDa filtration column but with the
addition of 0.5 M HAc. Both samples were lyophilized and redissolved
in the original volume of 20 L of 0.5 M HAc before Western blot
analysis.
MMP Breakdown of Type II Collagen
To determine whether the breakdown products that naturally occur in
the vitreous could result from MMP breakdown of type II collagen, we
tested a series of MMPs that are known to be present in the vitreous,
along with combinations thereof, for their ability to cleave type II
collagen. Pepsin-extracted type II collagen from osteoarthritic cartilage
was incubated with MMP-1, MMP-2, MMP-8, or MMP-9 alone or MMP-8
in combination with MMP-2, MMP-9, or both. MMPs were activated by
mixing in 1 mM final concentration of 4-aminophenylmercuric acetate
and by incubation for 1 or 2 hours at room temperature, depending on
the manufacturer’s instructions. Then, of each MMP, 0.5 U was added
to 20 g protein, and the mixtures were incubated for up to 2 hours
at 37°C. All MMPs were obtained from R&D Systems (Minneapolis,
MN).
Pepsin Breakdown of Denatured Type II Collagen
Pepsin, used in our collagen extraction procedure, is likely able to
degrade denatured type II collagen and can, therefore, also affect the
presence and sizes of naturally occurring breakdown products in the
vitreous. To evaluate this possibility, we subjected degraded type II
collagen to incubation with pepsin. First, pepsin-extracted type II
collagen from osteoarthritic cartilage was incubated for 1 hour with
MMP-8, as described. Then half the mixture was washed three times
with 0.5 M HAc using a 50 kDa filter (Amicon Ultra; Millipore), which
leaves intact type II collagen as well as col2-3/4C-short on top of the
filter. Pepsin was added in a final concentration of 1 mg/mL in 0.5 M
HAc to half of this sample. As a control, the other half of the sample
consisted of 0.5 M HAc without pepsin. These samples were incubated
for 24 hours at 4°C, similar to the pepsin extraction procedure applied
to type II collagen from human vitreous. Both samples consisted of 20
g type II collagen in a volume of 150 L
The other half of the MMP-8 cleaved mixture was used for analysis
of the denaturation by incubation with -chymotrypsin because this
enzyme can fully degrade denatured type II collagen.22 First, EDTA was
added in a final concentration of 2 mM to inactivate MMP-8. Then
-chymotrypsin was added to half this sample in a final concentration
of 0.1 mg/mL in 50 mM Tris, 10 mM CaCl2, 150 mM NaCl, and 0.05%
Brij-35 (TCNB). As a control, TCNB without the enzyme was added to
the other half of the sample. The mixtures were incubated for 1 hour
at 37°C. These samples also consisted of 20 g type II collagen in a
volume of 150 L. All samples were subjected to Western blot analysis
for the presence of type II collagen and col2-3/4C-short.
RESULTS
Immunohistochemistry
Immunohistochemistry repeatedly resulted in positive staining
of all three vitreous bodies when the 3/4C-short antibody was
used on sections of a human eye (Fig. 1A). The staining pattern
was similar to, but weaker than, the type II collagen-stained
sections of the same eye (Fig. 1C). Both type II collagen and
col2-3/4C-short stained darkest in the vitreous cortex, where
collagen concentrations are higher than in the central vitre-
ous.1 Figures 1A to 1D show the results from the 55-year-old
donor. Healthy-appearing cartilage from an osteoarthritic knee,
which was used as a negative control, showed no binding of
the col2-3/4C-short antibody (Fig. 1F), whereas the positive-
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control osteoarthritic cartilage areas from the same knee did
stain (Fig. 1E).
Western Blot Analysis
Protein extracts obtained from the pellets of centrifuged pools
of vitreous bodies (P25-P, P45-P, and P65-P) were subjected to
Western blot analysis. By using the mouse antibody against
type II collagen, intact type II collagen and several fragments of
type II collagen were found in all age groups (Fig. 2). Although
the protein concentrations used in all age groups were equal,
both type II collagen and its breakdown products presented as
more intensely stained bands in the younger pools. When P25-P
was set arbitrarily at 100%, the average type II collagen con-
centrations in P45-P and P65-P were 21% and 10%, respectively,
as shown by densitometry. The supernatant that was obtained
after centrifugation of the vitreous body pools was subjected to
Western blot analysis using the same type II collagen antibody.
No type II collagen fragments were detected in either the
untreated supernatants or in the concentrated supernatants
(data not shown). To confirm the collagenous nature of the
fragments detected by Western blot analysis, an aliquot of P25-P
was treated with bacterial collagenase VII. Figure 3 shows that
all fragments indeed disappear after collagenase digestion.
Western blot analysis of the pepsin solution showed that this
solution did not immunologically interfere with type II colla-
gen and the range of breakdown products (not shown).
Western blot analysis of proteins isolated from the vitreous
pellets and supernatants were also stained with the specific
col2-3/4C-short antibody. In addition, concentrated superna-
tants were analyzed to detect the possible presence of the
specific neoepitope on type II collagen fragments smaller than
50 kDa. Earlier attempts had demonstrated that the fraction
containing proteins larger than 50 kDa could not be concen-
trated that much because of the high noncollagenous protein
content, which led to nonspecific staining of the blotting
membrane (not shown). In all cases, no specific binding was
observed. The antibody did bind when a control sample con-
sisting of vitreous type II collagen cleaved by MMP-8 was used,
thereby confirming its ability to recognize the specific neo-
epitope by Western blot analysis (Fig. 4). A 20% gel was used
to detect possible small fragments that contained the neo-
epitope, but no bands were found (not shown).
Slot Blot Analysis
We hypothesized that the fragments containing the col2-3/4C-
short epitope could be undetectable by Western blot analysis
because they were so small they would run off the SDS-PAGE
gels or they were bound to or aggregated with other proteins.
Therefore, we decided to perform slot blot analysis with the
vitreous supernatants obtained after centrifugation and with
the isolated vitreous collagen. Specific binding of the antibody
was seen as a result (Fig. 5). Staining of the supernatants was
FIGURE 1. Immunohistochemistry of
human vitreous and human cartilage.
Eye sections were analyzed for the
presence of (A) col2-3/4C-short and
(C) type II collagen. The staining pat-
terns of these antibodies were similar,
though the intensity of the col2-3/4C-
short staining was weaker. Negative
controls of the eye sections (B, col2-3/
4C-short; D, type II collagen) showed
no aspecific binding of secondary anti-
bodies. The specificity of the antibody
against col2-3/4C-short was tested on
(E) osteoarthritic and (F) healthy carti-
lage sections. Staining was faint in the
osteoarthritic cartilage and absent
from the healthy cartilage. Antibodies
used were (C) mouse-anti–type II col-
lagen (ab-3) and (A, E) rabbit-anti–
col2-3/4C-short.
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light, but specific, and hardly showed any variation with aging.
The staining intensity of the pepsin extracts decreased with
aging, finally resulting in an even lighter staining than found in
the supernatant of P65. The negative control of the slot blot
was blank.
Type II Collagen Breakdown by Commercially
Available MMPs
Because we were interested in the range and nature of type II
collagen breakdown products found in the vitreous pools, we
tried to simulate the breakdown process with commercially
available MMPs known to occur in the vitreous body (MMP-1,
MMP-2, MMP-8, MMP-9)18,19 (Fig. 6). Cleavage of type II colla-
gen isolated from osteoarthritic cartilage by MMP-1 and MMP-8
resulted in the specific breakdown product col2-3/4C-short,
but not in the naturally occurring breakdown products in the
vitreous. An MMP-8 cleaved sample was used for further deg-
radation by MMP-2 and MMP-9. This resulted in the complete
disappearance of all type II collagen fragments. Incubation
with MMP-2 alone resulted in complete degradation of type II
collagen, thereby forming a weakly stained band between 50
and 75 kDa, but not the banding pattern seen in the vitreous.
A reduction in staining of the intact type II collagen band was
seen after 120 minutes of incubation with MMP-9 alone, but no
clear new breakdown products were formed.
Comparison of Type II Collagen Breakdown
Products in Vitreous and Cartilage
To investigate whether type II collagen degradation in the
vitreous body occurred as in other type II collagen–containing
tissues, we compared the vitreous breakdown products with
breakdown products that naturally occur in osteoarthritic ar-
ticular cartilage. These collagen fragments appeared to be of
similar size (Fig. 7).
Effect of Postmortem Time
On Western blot analysis, porcine eyes showed a pattern of
type II collagen breakdown products different from that of
human eyes. Storage of porcine eyes at 4°C for 24 hours
resulted in slightly more lightly stained bands of the break-
down products. One-week storage at 4°C resulted in a further
reduction in staining. No new breakdown products were
formed (Fig. 8).
Type II Collagen Breakdown by Pepsin
Incubation of MMP-8–cleaved type II collagen with pepsin
resulted in the formation of two visible breakdown products
(Fig. 9A), comparable in size to two of the protein bands found
in pepsin-extracted vitreous type II collagen (86 kDa and 57
kDa; Fig. 9C). These newly formed bands did not bind to the
col2-3/4C-short antibody (Fig. 9B). When MMP-8 cleaved type
II collagen was incubated with -chymotrypsin, all protein
bands on Western blot analysis disappeared, thereby confirm-
ing that type II collagen had denatured after cleavage by
MMP-8.
DISCUSSION
With the use of three different techniques, immunohistochem-
istry, Western blot analysis, and slot blot analysis, we found
indications of active enzymatic breakdown of type II collagen
in the human vitreous body. We also found evidence of MMP
involvement, but MMPs alone could not account for all our
observations.
Immunohistochemistry showed the presence of the specific
type II collagen breakdown product col2-3/4C-short in the vitre-
FIGURE 3. Western blot showing that collagenase treatment confirms
the collagen nature of the vitreous fragments. Addition of collagenase
type VII to the pepsin extract of the vitreous pool P25 resulted in
complete disappearance of all protein bands. This validated their col-
lagenous origin. Right lane, molecular weight marker. The blot was
stained with mouse-anti–type II collagen (ab-3).
FIGURE 2. Western blot analysis shows an apparent decrease in type
II collagen and its breakdown products in the vitreous with age. In
human vitreous, type II collagen and its breakdown products are
present in the pepsin-extracted pellets of all age groups. Compared
with total concentrations of isolated protein, the darkest stained type
II collagen bands were found in the younger age group. P25-P, P45-P, and
P65-P are the different pools, each consisting of four vitreous bodies.
The values after P indicate the mean ages of the donors. Staining was
performed with mouse-anti–type II collagen (ab-3). Left lane, molecu-
lar weight marker.
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ous, pointing to MMP-induced breakdown of type II collagen. The
MMP types that cleave intact type II collagen between amino
acids Gly775 and Leu/Ile776 are MMP-1, MMP-8, and MMP-13.
Because MMP-1 and MMP-8 are found in the vitreous,18,19 it is
likely that these are also active in the vitreous.
Western blot analysis demonstrated a range of type II col-
lagen degradation products, but none of these contained the
col2-3/4C-short epitope that we detected on blot after MMP-8
digestion of type II collagen. We ran our samples on 20%
acrylamide gels. This limited the minimal size of proteins to be
detected to approximately 10 kDa. It is possible that, after
initial cleavage by MMP-1 or MMP-8, the resultant breakdown
products were further cleaved by the same or other enzymes.
In addition, pepsin extraction might have resulted in a loss of
the col2-3/4C-short epitope. Figure 9 shows that the MMP-8–
induced type II collagen breakdown product is further cleaved
by pepsin and that the resultant smaller type II collagen break-
down products cannot be detected by the specific col2-3/4C-
short antibody. Epitopes that bind antibodies can be as small as
6 amino acids; therefore, fragments recognized by antibodies
can theoretically be of such low molecular weight that they are
missed by Western blot analysis. Therefore, extensive enzy-
matic breakdown may result in positive immunohistochemistry
but negative Western blot analysis. By slot blot analysis, which
enables detection of smaller fragments, the specific neoepitope
was detected, thereby confirming the immunohistochemical
data. The neoepitope was detected primarily in the pepsin
extracts. Furthermore, the pepsin extracts showed an age-
related decrease of neoepitope so that, as a result, at an average
age of 65 years, the concentration was even lower than in the
supernatants. This indicated that at a young age type II collagen
is already cleaved by MMPs and that the formed fragments are
likely even further digested enzymatically. It was possible that
the smallest neoepitope-containing fragments could be too
small to stick to the blotting membrane and, therefore, could
be undetectable. In future research, enzyme-linked immu-
nosorbent assay should be used for the quantification of all
neoepitope-containing fragments.
The breakdown products detected by Western blot analysis
in the different age groups were similarly sized, but the
amounts of the intact type II collagen and of its breakdown
products seemed to decrease with aging, even when similar
FIGURE 4. Western blot analysis of the vitreous for the presence of col2-3/4C-short. The specific antibody against col2-3/4C-short was tested for
its functionality in Western blot analysis. (A) Therefore, intact type II collagen from the vitreous (arrowhead) was cleaved with MMP-8, which
resulted in the disappearance of intact type II collagen and the appearance of the specific 3/4- and 1/4-breakdown products. Stained with
mouse-anti–type II collagen (ab-2). Some aspecific staining was seen on the 3/4 breakdown product. (B–D) Stained with the rabbit antibody against
col2-3/4C-short. (B) This antibody binds to the 3/4-breakdown product (arrow) but not the 1/4-breakdown product. (C, D) Binding of the
col2-3/4C-short was not found in the pepsin extracts of the vitreous pellets or in the supernatants. Molecular weight markers are shown in either
the far right or the far left lane of each Western blot.
FIGURE 5. Slot blot of vitreous samples from pools P25, P45, and P65.
Supernatants (P25-S, P45-S, and P65-S) and pepsin extracts (P25-P, P45-P,
and P65-P) were slot blotted, and the filter was stained with the rabbit-
anti–col2-3/4C-short antibody. With aging, the fragment col2-3/4C-
short decreased in the pepsin extracts until in P65-P the detectable
concentration was lower than found in the supernatants. No obvious
differences in staining intensity can be seen in the supernatants. Add-
ing MMP-8 to purified type II collagen from cartilage (col2MMP8),
which served as a positive control, gave specific staining of this band,
thereby confirming the presence of col2-3/4C-short.
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protein amounts were loaded on the gel. This seemed to
contradict earlier studies describing a constant collagen con-
tent in the vitreous during aging.23,24 Three scenarios might
have contributed to this observation. First, the accumulation of
advanced glycation end products (AGEs), which we observed
in the vitreous body,25 can result in lower extractable collagen
concentrations. In other ECMs that contain long-lived proteins,
it has been demonstrated that AGEs negatively affect pepsin
digestion of the matrix, thereby resulting in lower extractable
amounts of collagen26 and possibly of collagen fragments.
Second, at least part of this decrease in protein concentrations
can be explained by the rise in noncollagenous proteins in the
vitreous that occurs with aging, resulting in a shift in the ratio
of collagenous and noncollagenous proteins. Previous research
has shown that noncollagenous protein concentrations in-
crease by approximately 50% from 10 to 50 years to 50 to 80
years.23 In our own experiments, we found an increase in
noncollagenous proteins of 50% from the age of approximately
20 years to approximately 60 years.25 Third, some AGEs can
absorb light of 280 nm,27,28 the wavelength we used to deter-
mine protein concentrations, and this might have caused inac-
curacies in our measurements. The higher amount of AGEs
seen in older vitreous bodies can therefore be mistaken for a
higher protein concentration of the sample. However, because
of the small amounts of protein that we could extract from the
FIGURE 6. Western blot showing
degradation by MMP-1, MMP-2,
MMP-8, and MMP-9 of intact pepsin
extracted type II collagen from os-
teoarthritic cartilage. (A) Cleavage by
MMP-1 and MMP-8 resulted in the
specific 3/4 breakdown product.
When MMP-8 was combined with
MMP-2, MMP-9, or both, this product
also disappeared. (B) Incubation
with MMP-2 resulted in the quick dis-
appearance of intact type II collagen
and the formation of a weakly stained
product at approximately 65 kDa (ar-
row). Type II collagen appeared
more resistant to MMP-9 but here
also the amount of collagen de-
creased over time, though no clear
new breakdown products were
formed. The antibody used was
mouse-anti–type II collagen (ab-3).
FIGURE 7. Vitreous and osteoarthritic cartilage contain similar type II
collagen breakdown products. Comparison of type II collagen break-
down products from vitreous (P25-P) and osteoarthritic cartilage by
Western blot analysis. The blot was stained with mouse-anti–type II
collagen (ab-3).
FIGURE 8. Western blot showing the effect of postmortem time on
porcine vitreous. Storage of porcine eyes for 24 hours at 4°C resulted
in a slight reduction in staining intensity of some type II collagen
breakdown products. One-week storage at 4°C resulted in further
reduction in staining intensity. No new breakdown products were
found. The blot was stained with mouse-anti–type II collagen (ab-3).
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human vitreous, we were obliged to use this method to esti-
mate protein concentrations.
The possible effects of aging changes on the extractability
of collagen breakdown products makes it difficult to establish
a direct relationship between the amount of synchisis and the
extent of enzymatic breakdown in the vitreous. In addition, it
is likely that the breakdown products, as shown by Western
blot analysis, are intermediate products that will be cleaved
further. Whether early syneresis in highly myopic eyes is
caused by more extensive enzymatic collagen breakdown can-
not be deduced from this study because only eyes of appar-
ently normal size were included.
One question that remains unresolved is which enzyme or
enzymes are responsible for the type II collagen breakdown
products we found by Western blot analysis. Cleavage of type
II collagen by MMP-1 and MMP-8, both known to be present in
the vitreous, did not produce these type II collagen breakdown
products, and a combination of MMP-8 with MMP-2 or MMP-9,
or both, produced such extensive breakdown that clear frag-
ments were no longer detectable by Western blot analysis. The
weakly stained band that was formed on degradation by MMP-2
alone could correspond to one of the naturally occurring
breakdown products in the vitreous, but MMP-2 cannot ex-
plain the range of other breakdown products that we repeat-
edly found. Although MMP-9 was able to digest some of the
type II collagen, we did not find any larger fragments. MMP-9,
though, is not supposed to be able to cleave the collagen triple
helix.29 It is possible that our type II collagen, which was
isolated from diseased osteoarthritic cartilage, contained some
monomeric collagen that could be degraded by MMP-9. To-
gether, these observations suggest that other type II collagen
degrading enzymes are present in the vitreous. However, we
cannot exclude that in the combined MMP experiments, the
concentrations of MMP-2 and MMP-9 were so high that possi-
ble intermediate breakdown products were degraded too
quickly for detection. Such breakdown products might well be
detectable in the presence of lower MMP concentrations. Fur-
thermore, an effect of pepsin extraction on the sizes of the
breakdown products cannot be fully excluded. We showed
that digestion by pepsin of MMP-8–cleaved type II collagen
resulted in the formation of two breakdown products sized
similarly to those found in pepsin-extracted vitreous type II
collagen. The other breakdown products found in the vitreous
extract could not be reproduced by pepsin digestion. Given
that collagen can become denatured in other ways—enzymat-
ically,30 by free radicals,31 or by physical denaturation32—
either before or during the extraction procedure, we cannot
completely exclude any effects of these on the observed pro-
tein bands. Future studies are needed to examine these possi-
bilities.
In the study with porcine eyes we found that storage of
intact eyes for up to 1 week after death at 4°C did not result in
the formation of additional type II collagen breakdown prod-
ucts in the vitreous. Porcine eyes were chosen for this study
because ages and postmortem times could be standardized.
However, we realize that porcine and human eyes are not
equal and can, for example, show differences in types and
expression of proteinases. Therefore, postmortem effects in
our results using human eyes cannot fully be excluded.
In conclusion, our results provide evidence that enzymatic
breakdown of the collagen fibrils is probably one of the mech-
anisms that causes age-related changes in the vitreous. Enzy-
matic activity in the vitreous was already hypothesized by
Bishop et al.,3 who found a loss of proteoglycans from the
collagen fibrils with aging caused by enzymatic breakdown.
Proteoglycan loss and type II collagen breakdown are also seen
in osteoarthritic cartilage, where collagen breakdown products
are found primarily at sites where proteoglycans are de-
pleted.33,34 This, combined with the finding that type II colla-
gen breakdown products from the vitreous are similar to those
in cartilage, suggests that similar enzymes may be involved in
vitreous and cartilage collagen breakdown. Future research
should be directed at identifying these enzymes.
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